VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 107 filers reported holding VISTAGEN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 5.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $5 | +66.7% | 33,959 | 0.0% | 0.00% | – |
Q4 2022 | $3 | -99.9% | 33,959 | +89.1% | 0.00% | – |
Q3 2022 | $3,000 | -96.2% | 17,954 | -79.9% | 0.00% | – |
Q2 2022 | $79,000 | -28.2% | 89,354 | +1.1% | 0.00% | – |
Q1 2022 | $110,000 | -33.3% | 88,371 | +4.7% | 0.00% | – |
Q4 2021 | $165,000 | +7.8% | 84,371 | +51.0% | 0.00% | – |
Q3 2021 | $153,000 | -14.5% | 55,871 | -1.6% | 0.00% | – |
Q2 2021 | $179,000 | +113.1% | 56,771 | +43.7% | 0.00% | – |
Q1 2021 | $84,000 | – | 39,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 11,728,033 | $36,943,000 | 14.76% |
VR Adviser, LLC | 16,047,286 | $50,549,000 | 6.13% |
COMMODORE CAPITAL LP | 3,331,315 | $10,494,000 | 3.66% |
Ghost Tree Capital, LLC | 2,000,000 | $6,300,000 | 1.73% |
EPIQ PARTNERS, LLC | 932,956 | $2,939,000 | 1.47% |
SPHERA FUNDS MANAGEMENT LTD. | 4,080,673 | $12,854,000 | 0.87% |
SILVERARC CAPITAL MANAGEMENT, LLC | 615,547 | $1,939,000 | 0.86% |
HighVista Strategies LLC | 308,096 | $971,000 | 0.69% |
NEA Management Company, LLC | 16,302,596 | $51,353,000 | 0.67% |
Nicholas Investment Partners, LP | 2,753,880 | $8,675,000 | 0.54% |